trimethyl(1,2,4-triazol-1-yl)silane

We are trimethyl(1,2,4-triazol-1-yl)silane CAS:18293-54-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:trimethyl(1,2,4-triazol-1-yl)silane
CAS.NO:18293-54-4
Synonyms:1-Trimethylsilyl-1,2,4-triazole; trimethylsilyl-1,2,4-triazole;
Molecular Formula:C5H11N3Si
Molecular Weight:141.24600
 
Physical and Chemical Properties:
Density:0.989;
Boiling point:74^oC;
Flash point:55^oC;
Index of Refraction:1.461;
 
Specification:
Appearance:Clear clear liquid
Purity(GC):≥98.0%
 
Packing:210 L/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used for production of pharmaceuticals.




Related News: Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.Ácido 2,3-dihidrobenzofuran-5-acético CAS:69999-16-2 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.2-Chloro-4-(Methylsulfonyl)Benzoic Acid CAS:53250-83-2 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.1-CLORO-4-FENILFTAZALINA CAS:10132-01-1 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.